Kamari Pharma is a biopharmaceutical company aiming to develop and commercialize proprietary small molecule (SMC) inhibitors of TRPV3, a cation channel expressed primary in keratinocytes, for the treatment of dermatological conditions with unmet need.

Click here to read Kameri Pharma’s profile

biopharmaceuticals
Private
Visit Website

NA

Additional Portfolio Companies
Adicet Bio
AgomAb Therapeutics
ArQule
Cathworks
Camel-IDS
Dynacure
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Genocea
Horama
IMEL Biotherapeutics
Immunic Therapeutics
Kamari Pharma
Keros Therapeutics
Kite Pharma
Levation Pharma
LogicBio Therapeutics
Lutris Pharma
Mereo BioPharma
Metabomed
NovellusDX
Ocon Medical
Prevail Therapeutics
PACT Pharma
Pi Therapeutics
ProQR
Protalix
Raziel Therapeutics
ReWalk
Saniona
SilverBack Therapeutics
Stargazer Pharmaceuticals
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
Vascular Graft Solutions
UroGen
V-Wave
December 27, 2019